Efficacy of switching from existing anti-vascular endothelial growth factor drugs to ranibizumab biosimilar in neovascular age-related macular degeneration. [PDF]
Ota H +5 more
europepmc +1 more source
This work proposes a multifunctional Bi2WO6:Yb,Er@CuS@CS nanocomposite that integrates photodynamic therapy (PDT), near‐infrared‐triggered photothermal therapy (PTT), and Cu2+ release for infected wound repair. The nanocomposite demonstrates enhanced antibacterial efficacy via combined PDT, PTT, and Cu2+ release, effective immunomodulatory by mild ...
Yihao Sun +9 more
wiley +1 more source
Serologic parameters in young patients with retinal vein occlusion treated with anti-vascular endothelial growth factor. [PDF]
Niu TT, Xiao Y, Lyu WJ, Zhou H.
europepmc +1 more source
This study developed a double‐network hydrogel with piezoelectric properties, exhibiting excellent antibacterial activity and promoting fibroblast migration, angiogenesis, and lymphangiogenesis through piezoelectric stimulation, thereby accelerating the healing of infected chronic wounds.
Xiang Li +7 more
wiley +1 more source
Treatment intervals with first-generation anti-vascular endothelial growth factor drugs: evaluating the unmet need in a real-world neovascular age-related macular degeneration national database. [PDF]
Zarranz-Ventura J +8 more
europepmc +1 more source
Peptide dendrimer–based nanoplatform with mitochondria‐targeting capability was developed for synergistic chemo‐photothermal therapy. The system promotes efficient transcytosis, induces mitochondrial dysfunction, triggers immunogenic cell death (ICD), and enhance antitumor immunity by promoting dendritic cell maturation and T‐cell activation, resulting
Min Li +15 more
wiley +1 more source
Vitrectomy Alone Versus Anti-vascular Endothelial Growth Factor (Anti-VEGF) Therapy Prior to Vitrectomy for Diabetic Vitreous Hemorrhage: A Systematic Review and Meta-Analysis. [PDF]
Alhaj SS +4 more
europepmc +1 more source
Mild antiresorptive activity of an anti-vascular endothelial growth factor A antibody and sunitinib in a rat model of bone resorption. [PDF]
Aguirre JI +4 more
europepmc +1 more source
Cost-effectiveness of anti-vascular endothelial growth factor and macular laser treatments for people with centre-involving diabetic macular oedema and central retinal thickness of at least 400 micrometres. [PDF]
Luckham K +10 more
europepmc +1 more source

